ReP USP - Resultado da busca

Artigo de periodico
Plazomicin for infections caused by carbapenem-resistant Enterobacteriaceae (2019)
McKinnell, James A.; Jubb, Adrian M.; Daikos, George L.; Bollela, Valdes Roberto
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: BACTEREMIA, ENTEROBACTERIACEAE, INFECÇÕES BACTERIANAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MCKINNELL, James A.; JUBB, Adrian M.; DAIKOS, George L.; BOLLELA, Valdes Roberto. Plazomicin for infections caused by carbapenem-resistant Enterobacteriaceae. The New England Journal of Medicine, Wathan, v. 380, n. 8, p. 791-793, 2019. Disponível em: < https://doi.org/10.1056/NEJMc1807634 > DOI: 10.1056/NEJMc1807634.
APA
McKinnell, J. A., Jubb, A. M., Daikos, G. L., & Bollela, V. R. (2019). Plazomicin for infections caused by carbapenem-resistant Enterobacteriaceae. The New England Journal of Medicine, 380( 8), 791-793. doi:10.1056/NEJMc1807634
NLM
McKinnell JA, Jubb AM, Daikos GL, Bollela VR. Plazomicin for infections caused by carbapenem-resistant Enterobacteriaceae [Internet]. The New England Journal of Medicine. 2019 ; 380( 8): 791-793.Available from: https://doi.org/10.1056/NEJMc1807634
Vancouver
McKinnell JA, Jubb AM, Daikos GL, Bollela VR. Plazomicin for infections caused by carbapenem-resistant Enterobacteriaceae [Internet]. The New England Journal of Medicine. 2019 ; 380( 8): 791-793.Available from: https://doi.org/10.1056/NEJMc1807634
Artigo de periodico
Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction (2019)
Solomon, S. D.; McMurray, J. J. V.; Anand, I. S.; Ge, J.; Lam, C. S. P; Maggioni, A. P.; Martinez, F.; Packer, M.; Pfeffer, M. A.; Simões, Marcus Vinícius
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: ANGIOTENSINAS, DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA CARDÍACA, HIPOTENSÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOLOMON, S. D.; MCMURRAY, J. J. V.; ANAND, I. S.; et al. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. The New England Journal of Medicine, Waltham, v. 381, n. 17, p. 1609-1620, 2019. Disponível em: < https://doi.org/10.1056/NEJMoa1908655 > DOI: 10.1056/NEJMoa1908655.
APA
Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., et al. (2019). Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. The New England Journal of Medicine, 381( 17), 1609-1620. doi:10.1056/NEJMoa1908655
NLM
Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Simões MV. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction [Internet]. The New England Journal of Medicine. 2019 ; 381( 17): 1609-1620.Available from: https://doi.org/10.1056/NEJMoa1908655
Vancouver
Solomon SD, McMurray JJV, Anand IS, Ge J, Lam CSP, Maggioni AP, Martinez F, Packer M, Pfeffer MA, Simões MV. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction [Internet]. The New England Journal of Medicine. 2019 ; 381( 17): 1609-1620.Available from: https://doi.org/10.1056/NEJMoa1908655
Artigo de periodico
Effects of serelaxin in patients with acute heart failure (2019)
Metra, M.; Teerlink, J. R.; Cotter, G.; Davison, B. A.; Felker, G. M.; Filippatos, G.; Greenberg, B. H.; Pang, P. S.; Ponikowski, P.; Simões, Marcus Vinícius
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇA AGUDA, DOENÇAS CARDIOVASCULARES, INSUFICIÊNCIA CARDÍACA, PROTEÍNAS RECOMBINANTES, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
METRA, M.; TEERLINK, J. R.; COTTER, G.; et al. Effects of serelaxin in patients with acute heart failure. The New England Journal of Medicine, Waltham, v. 381, n. 8, p. 716-726, 2019. Disponível em: < https://doi.org/10.1056/NEJMoa180129 > DOI: 10.1056/NEJMoa180129.
APA
Metra, M., Teerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., et al. (2019). Effects of serelaxin in patients with acute heart failure. The New England Journal of Medicine, 381( 8), 716-726. doi:10.1056/NEJMoa180129
NLM
Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Simões MV. Effects of serelaxin in patients with acute heart failure [Internet]. The New England Journal of Medicine. 2019 ; 381( 8): 716-726.Available from: https://doi.org/10.1056/NEJMoa180129
Vancouver
Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Simões MV. Effects of serelaxin in patients with acute heart failure [Internet]. The New England Journal of Medicine. 2019 ; 381( 8): 716-726.Available from: https://doi.org/10.1056/NEJMoa180129
Artigo de periodico
Complete revascularization with multivessel PCI for myocardial infarction (2019)
Mehta, Shamir R; Wood, David A.; Storey, Robert F.; Mehran, Roxana; Bainey, Kevin R.; Nguyen, Helen; Meeks, Brandi; Di Pasquale, Giuseppe; López-Sendon, Jose; Marin Neto, José Antonio
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, REVASCULARIZAÇÃO MIOCÁRDICA, INFARTO DO MIOCÁRDIO, CONTENEDORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEHTA, Shamir R; WOOD, David A.; STOREY, Robert F.; et al. Complete revascularization with multivessel PCI for myocardial infarction. The New England Journal of Medicine, Waltham, v. 380, n. 15, p. 1411-1421, 2019. Disponível em: < https://doi.org/10.1056/NEJMoa1907775 > DOI: 10.1056/NEJMoa1907775.
APA
Mehta, S. R., Wood, D. A., Storey, R. F., Mehran, R., Bainey, K. R., Nguyen, H., et al. (2019). Complete revascularization with multivessel PCI for myocardial infarction. The New England Journal of Medicine, 380( 15), 1411-1421. doi:10.1056/NEJMoa1907775
NLM
Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendon J, Marin Neto JA. Complete revascularization with multivessel PCI for myocardial infarction [Internet]. The New England Journal of Medicine. 2019 ; 380( 15): 1411-1421.Available from: https://doi.org/10.1056/NEJMoa1907775
Vancouver
Mehta SR, Wood DA, Storey RF, Mehran R, Bainey KR, Nguyen H, Meeks B, Di Pasquale G, López-Sendon J, Marin Neto JA. Complete revascularization with multivessel PCI for myocardial infarction [Internet]. The New England Journal of Medicine. 2019 ; 380( 15): 1411-1421.Available from: https://doi.org/10.1056/NEJMoa1907775
Artigo de periodico
Health Effects of Overweight and Obesity in 195 Countries over 25 Years (2017)
Afshin, Ashkan; Santos, Iamar S.
Source: The New England Journal of Medicine. Unidade: FM
Subjects: OBESIDADE, FATORES DE RISCO, ESTUDOS PROSPECTIVOS, PREVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AFSHIN, Ashkan; SANTOS, Iamar S. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. The New England Journal of Medicine, Boston, v. 377, n. 1, p. 13-27, 2017. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614362 > DOI: 10.1056/NEJMoa1614362.
APA
Afshin, A., & Santos, I. S. (2017). Health Effects of Overweight and Obesity in 195 Countries over 25 Years. The New England Journal of Medicine, 377( 1), 13-27. doi:10.1056/NEJMoa1614362
NLM
Afshin A, Santos IS. Health Effects of Overweight and Obesity in 195 Countries over 25 Years [Internet]. The New England Journal of Medicine. 2017 ; 377( 1): 13-27.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614362
Vancouver
Afshin A, Santos IS. Health Effects of Overweight and Obesity in 195 Countries over 25 Years [Internet]. The New England Journal of Medicine. 2017 ; 377( 1): 13-27.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614362
Artigo de periodico
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease (2017)
Ataga, Kenneth I.; Kutlar, Abdullah; Kanter, Julie; Liles, Darla; Cancado, Rodolfo; Friedrisch, João; Guthrie, Troy H.; Knight-Madden, Jennifer; Alvarez, Ofelia A.; Gordeuk, Victor R.; Gualandro, Sandra; Colella, Marina P.; Smith, Wally R.; Rollins, Scott A.; Stocker, Jonathan W.; Rother, Russell P.
Source: The New England Journal of Medicine. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, PLACEBO, DOENÇAS HEMATOLÓGICAS, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ATAGA, Kenneth I.; KUTLAR, Abdullah; KANTER, Julie; et al. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease. The New England Journal of Medicine, Boston, v. 376, n. 5, p. 429-439, 2017. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMoa1611770 > DOI: 1056/NEJMoa1611770.
APA
Ataga, K. I., Kutlar, A., Kanter, J., Liles, D., Cancado, R., Friedrisch, J., et al. (2017). Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease. The New England Journal of Medicine, 376( 5), 429-439. doi:1056/NEJMoa1611770
NLM
Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease [Internet]. The New England Journal of Medicine. 2017 ; 376( 5): 429-439.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1611770
Vancouver
Ataga KI, Kutlar A, Kanter J, Liles D, Cancado R, Friedrisch J, Guthrie TH, Knight-Madden J, Alvarez OA, Gordeuk VR, Gualandro S, Colella MP, Smith WR, Rollins SA, Stocker JW, Rother RP. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease [Internet]. The New England Journal of Medicine. 2017 ; 376( 5): 429-439.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1611770
Artigo de periodico
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients (2017)
Ridker, Paul M.; Revkin, James; Amarenco, Pierre; Brunell, Robert; Curto, Madelyn; Civeira, Fernando; Flather, Marcus; Glynn, Robert J.; Gregoire, Jean; Jukema, J. Wouter; Karpov, Yuri; Kastelein, John J.P.; Koenig, Wolfgang; Lorenzatti, Alberto; Manga, Pravin; Masiukiewicz, Urszula; Miller, Michael; Mosterd, Arend; Murin, Jan; Nicolau, Jose C.; Nissen, Steven; Ponikowski, Piotr; Santos, Raul D.; Schwartz, Pamela F.; Soran, Handrean; White, Harvey; Wright, R. Scott; Vrablik, Michal; Yunis, Carla; Shear, Charles L.; Tardif, Jean-Claude
Source: The New England Journal of Medicine. Unidade: FM
Subjects: COLESTEROL, PLACEBO, ANTICORPOS MONOCLONAIS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIDKER, Paul M.; REVKIN, James; AMARENCO, Pierre; et al. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, Boston, v. 376, n. 16, p. 1527-1539, 2017. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488 > DOI: 10.1056/NEJMoa1701488.
APA
Ridker, P. M., Revkin, J., Amarenco, P., Brunell, R., Curto, M., Civeira, F., et al. (2017). Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. The New England Journal of Medicine, 376( 16), 1527-1539. doi:10.1056/NEJMoa1701488
NLM
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif J-C. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1527-1539.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488
Vancouver
Ridker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif J-C. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1527-1539.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1701488
Artigo de periodico
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab (2017)
Ridker, Paul M.; Tardif, Jean-Claude; Amarenco, Pierre; Duggan, William; Glynn, Robert J.; Jukema, J. Wouter; Kastelein, John J.P.; Kim, Albert M.; Koenig, Wolfgang; Nissen, Steven; Revkin, James; Rose, Lynda M.; Santos, Raul D.; Schwartz, Pamela F.; Shear, Charles L.; Yunis, Carla
Source: The New England Journal of Medicine. Unidade: FM
Subjects: COLESTEROL, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICORPOS MONOCLONAIS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIDKER, Paul M.; TARDIF, Jean-Claude; AMARENCO, Pierre; et al. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. The New England Journal of Medicine, Boston, v. 376, n. 16, p. 1517-1526, 2017. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062 > DOI: 10.1056/NEJMoa1614062.
APA
Ridker, P. M., Tardif, J. -C., Amarenco, P., Duggan, W., Glynn, R. J., Jukema, J. W., et al. (2017). Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab. The New England Journal of Medicine, 376( 16), 1517-1526. doi:10.1056/NEJMoa1614062
NLM
Ridker PM, Tardif J-C, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1517-1526.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062
Vancouver
Ridker PM, Tardif J-C, Amarenco P, Duggan W, Glynn RJ, Jukema JW, Kastelein JJP, Kim AM, Koenig W, Nissen S, Revkin J, Rose LM, Santos RD, Schwartz PF, Shear CL, Yunis C. Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab [Internet]. The New England Journal of Medicine. 2017 ; 376( 16): 1517-1526.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1614062
Artigo de periodico
Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression (2017)
Brunoni, A. R.; Moffa, A. H.; Sampaio-Junior, B.; Borrione, L.; Moreno, M. L.; Fernandes, R. A.; Veronezi, B. P.; Nogueira, B. S.; Aparicio, L. V. M.; Razza, L. B.; Chamorro, R.; Tort, L. C.; Fraguas, R.; Lotufo, P. A.; Gattaz, W. F.; Fregni, F.; Benseñor, I. M.
Source: The New England Journal of Medicine. Unidades: RUSP, FM
Subjects: DEPRESSÃO, ESTUDOS RANDOMIZADOS, BIOMARCADORES, ESTIMULAÇÃO CEREBRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUNONI, A. R.; MOFFA, A. H.; SAMPAIO-JUNIOR, B.; et al. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression. The New England Journal of Medicine, Boston, v. 376, n. 26, p. 2523-2533, 2017. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMoa1612999 > DOI: 10.1056/NEJMoa1612999.
APA
Brunoni, A. R., Moffa, A. H., Sampaio-Junior, B., Borrione, L., Moreno, M. L., Fernandes, R. A., et al. (2017). Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression. The New England Journal of Medicine, 376( 26), 2523-2533. doi:10.1056/NEJMoa1612999
NLM
Brunoni AR, Moffa AH, Sampaio-Junior B, Borrione L, Moreno ML, Fernandes RA, Veronezi BP, Nogueira BS, Aparicio LVM, Razza LB, Chamorro R, Tort LC, Fraguas R, Lotufo PA, Gattaz WF, Fregni F, Benseñor IM. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression [Internet]. The New England Journal of Medicine. 2017 ; 376( 26): 2523-2533.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1612999
Vancouver
Brunoni AR, Moffa AH, Sampaio-Junior B, Borrione L, Moreno ML, Fernandes RA, Veronezi BP, Nogueira BS, Aparicio LVM, Razza LB, Chamorro R, Tort LC, Fraguas R, Lotufo PA, Gattaz WF, Fregni F, Benseñor IM. Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression [Internet]. The New England Journal of Medicine. 2017 ; 376( 26): 2523-2533.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1612999
Artigo de periodico
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist (2017)
Taylor, Hugh S.; Giudice, Linda C.; Lessey, Bruce A.; Abrao, Mauricio S.; Kotarski, Jan; Archer, David F.; Diamond, Michael P.; Surrey, Eric; Johnson, Neil P.; Watts, Nelson B.; Gallagher, J. Chris; Simon, James A.; Carr, Bruce R.; Dmowski, W. Paul; Leyland, Nicholas; Rowan, Jean P.; Duan, W. Rachel; Ng, Juki; Schwefel, Brittany; Thomas, James W.; Jain, Rita I.; Chwalisz, Kristof
Source: The New England Journal of Medicine. Unidade: FM
Subjects: FÁRMACOS (SISTEMA REPRODUTOR), DOR, ENDOMETRIOSE, HORMÔNIO LIBERADOR DE GONADOTROFINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAYLOR, Hugh S.; GIUDICE, Linda C.; LESSEY, Bruce A.; et al. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. The New England Journal of Medicine, Boston, v. 377, n. 1, p. 28-40, 2017. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMoa1700089 > DOI: 10.1056/NEJMoa1700089.
APA
Taylor, H. S., Giudice, L. C., Lessey, B. A., Abrao, M. S., Kotarski, J., Archer, D. F., et al. (2017). Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. The New England Journal of Medicine, 377( 1), 28-40. doi:10.1056/NEJMoa1700089
NLM
Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, Jain RI, Chwalisz K. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist [Internet]. The New England Journal of Medicine. 2017 ; 377( 1): 28-40.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1700089
Vancouver
Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, Jain RI, Chwalisz K. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist [Internet]. The New England Journal of Medicine. 2017 ; 377( 1): 28-40.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1700089
Artigo de periodico
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease (2017)
Lincoff, A. Michael; Nicholls, Stephen J.; Riesmeyer, Jeffrey S.; Barter, Philip J.; Brewer, H. Bryan; Fox, Keith A.A.; Gibson, C. Michael; Granger, Christopher; Menon, Venu; Montalescot, Gilles; Rader, Daniel; Tall, Alan R.; McErlean, Ellen; Wolski, Kathy; Ruotolo, Giacomo; Vangerow, Burkhard; Weerakkody, Govinda; Goodman, Shaun G.; Conde, Diego; McGuire, Darren K.; Nicolau, Jose C.; Leiva-Pons, Jose L.; Pesant, Yves; Li, Weimin; Kandath, David; Kouz, Simon; Tahirkheli, Naeem; Mason, Denise; Nissen, Steven E.
Source: The New England Journal of Medicine. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, COLESTEROL, DOENÇAS CARDIOVASCULARES, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LINCOFF, A. Michael; NICHOLLS, Stephen J.; RIESMEYER, Jeffrey S.; et al. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. The New England Journal of Medicine, Boston, v. 376, n. 20, p. 1933-1942, 2017. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMoa1609581 > DOI: 10.1056/NEJMoa1609581.
APA
Lincoff, A. M., Nicholls, S. J., Riesmeyer, J. S., Barter, P. J., Brewer, H. B., Fox, K. A. A., et al. (2017). Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. The New England Journal of Medicine, 376( 20), 1933-1942. doi:10.1056/NEJMoa1609581
NLM
Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease [Internet]. The New England Journal of Medicine. 2017 ; 376( 20): 1933-1942.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1609581
Vancouver
Lincoff AM, Nicholls SJ, Riesmeyer JS, Barter PJ, Brewer HB, Fox KAA, Gibson CM, Granger C, Menon V, Montalescot G, Rader D, Tall AR, McErlean E, Wolski K, Ruotolo G, Vangerow B, Weerakkody G, Goodman SG, Conde D, McGuire DK, Nicolau JC, Leiva-Pons JL, Pesant Y, Li W, Kandath D, Kouz S, Tahirkheli N, Mason D, Nissen SE. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease [Internet]. The New England Journal of Medicine. 2017 ; 376( 20): 1933-1942.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1609581
Artigo de periodico
Cluster-randomized, crossover trial of head positioning in acute stroke (2017)
Anderson, C. S.; Arima, H.; Lavados, P.; Billot, L.; Hackett, M. L.; Olavarria, V. V.; Muñoz Venturelli, P.; Brunser, A.; Peng, B.; Cui, L.; Pontes Neto, Octávio Marques
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: ACIDENTE VASCULAR CEREBRAL, FLUXO SANGUÍNEO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDERSON, C. S.; ARIMA, H.; LAVADOS, P.; et al. Cluster-randomized, crossover trial of head positioning in acute stroke. The New England Journal of Medicine, Boston, v. 376, n. 25, p. 2437-2447, 2017. Disponível em: < http://dx.doi.org/10.1056/NEJMoa1615715 > DOI: 10.1056/NEJMoa1615715.
APA
Anderson, C. S., Arima, H., Lavados, P., Billot, L., Hackett, M. L., Olavarria, V. V., et al. (2017). Cluster-randomized, crossover trial of head positioning in acute stroke. The New England Journal of Medicine, 376( 25), 2437-2447. doi:10.1056/NEJMoa1615715
NLM
Anderson CS, Arima H, Lavados P, Billot L, Hackett ML, Olavarria VV, Muñoz Venturelli P, Brunser A, Peng B, Cui L, Pontes Neto OM. Cluster-randomized, crossover trial of head positioning in acute stroke [Internet]. The New England Journal of Medicine. 2017 ; 376( 25): 2437-2447.Available from: http://dx.doi.org/10.1056/NEJMoa1615715
Vancouver
Anderson CS, Arima H, Lavados P, Billot L, Hackett ML, Olavarria VV, Muñoz Venturelli P, Brunser A, Peng B, Cui L, Pontes Neto OM. Cluster-randomized, crossover trial of head positioning in acute stroke [Internet]. The New England Journal of Medicine. 2017 ; 376( 25): 2437-2447.Available from: http://dx.doi.org/10.1056/NEJMoa1615715
Artigo de periodico-carta/editorial
Prolonged Shedding of Zika Virus Associated with Congenital Infection (2016)
Oliveira, Danielle Bruna Leal de ; Almeida, Flávia Jacqueline; Durigon, Edison Luiz ; Mendes, Érica Araújo ; Braconi, Carla Torres ; Santos, Robert Andreata; Cunha, Marielton Passos ; Alves, Rúbens Prince dos Santos; Pereira, Lennon Ramos; Melo, Stella Rezende; L. Neto, Daniel F.; Araujo, Danielle Bastos; Mesquita, Flávio da Silva ; Lazarini, Silvana Regina Favoretto; Sáfadi, Marco Aurélio Palazzi; Ferreira, Luís Carlos Souza ; Zanotto, Paolo Marinho de Andrade ; Botosso, Viviane Fongaro ; Berezin, Eitan Naaman
Source: The New England Journal of Medicine. Unidades: ICB, BIOINFORMÁTICA
Subjects: MICROBIOLOGIA, ZIKA VÍRUS, MICROCEFALIA, CÉREBRO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Danielle Bruna Leal de; ALMEIDA, Flávia Jacqueline; DURIGON, Edison Luiz; et al. Prolonged Shedding of Zika Virus Associated with Congenital Infection. The New England Journal of Medicine[S.l: s.n.], 2016.Disponível em: DOI: 10.1056/NEJMc1607583.
APA
Oliveira, D. B. L. de, Almeida, F. J., Durigon, E. L., Mendes, É. A., Braconi, C. T., Santos, R. A., et al. (2016). Prolonged Shedding of Zika Virus Associated with Congenital Infection. The New England Journal of Medicine. Waltham. doi:10.1056/NEJMc1607583
NLM
Oliveira DBL de, Almeida FJ, Durigon EL, Mendes ÉA, Braconi CT, Santos RA, Cunha MP, Alves RP dos S, Pereira LR, Melo SR, L. Neto DF, Araujo DB, Mesquita F da S, Lazarini SRF, Sáfadi MAP, Ferreira LCS, Zanotto PM de A, Botosso VF, Berezin EN. Prolonged Shedding of Zika Virus Associated with Congenital Infection [Internet]. The New England Journal of Medicine. 2016 ; 375( 12): 1202-1204.Available from: https://doi.org/10.1056/NEJMc1607583
Vancouver
Oliveira DBL de, Almeida FJ, Durigon EL, Mendes ÉA, Braconi CT, Santos RA, Cunha MP, Alves RP dos S, Pereira LR, Melo SR, L. Neto DF, Araujo DB, Mesquita F da S, Lazarini SRF, Sáfadi MAP, Ferreira LCS, Zanotto PM de A, Botosso VF, Berezin EN. Prolonged Shedding of Zika Virus Associated with Congenital Infection [Internet]. The New England Journal of Medicine. 2016 ; 375( 12): 1202-1204.Available from: https://doi.org/10.1056/NEJMc1607583
Artigo de periodico
Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy (2015)
Morillo, Carlos A.; Marin Neto, José Antonio; Avezum, Álvaro; Sosa-Estani, Sergio; Rassi Júnior, Anis; Rosas, Fernando; Villena, Erick; Quiroz, Roberto; Bonilla, Rina; Britto, Constança; Guhl, Felipe; Velázquez, Elsa; Bonilla, Laura; Meeks, Brandi; Rao-Melacini, Purnima; Pogue, Janice; Mattos, Antônio; Lazdins, Janis; Rassi, Anis; Connolly, Stuart J.; Yusuf, Salim; Schmidt, André
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: MIOCARDIOPATIA CHAGÁSICA, TERAPÊUTICA MÉDICA, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORILLO, Carlos A.; MARIN NETO, José Antonio; AVEZUM, Álvaro; et al. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. The New England Journal of Medicine, Waltham, v. 373, n. 14, p. 1295-1306, 2015. Disponível em: < http://dx.doi.org/10.1056/NEJMoa1507574 > DOI: 10.1056/NEJMoa1507574.
APA
Morillo, C. A., Marin Neto, J. A., Avezum, Á., Sosa-Estani, S., Rassi Júnior, A., Rosas, F., et al. (2015). Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. The New England Journal of Medicine, 373( 14), 1295-1306. doi:10.1056/NEJMoa1507574
NLM
Morillo CA, Marin Neto JA, Avezum Á, Sosa-Estani S, Rassi Júnior A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velázquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, Schmidt A. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy [Internet]. The New England Journal of Medicine. 2015 ; 373( 14): 1295-1306.Available from: http://dx.doi.org/10.1056/NEJMoa1507574
Vancouver
Morillo CA, Marin Neto JA, Avezum Á, Sosa-Estani S, Rassi Júnior A, Rosas F, Villena E, Quiroz R, Bonilla R, Britto C, Guhl F, Velázquez E, Bonilla L, Meeks B, Rao-Melacini P, Pogue J, Mattos A, Lazdins J, Rassi A, Connolly SJ, Yusuf S, Schmidt A. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy [Internet]. The New England Journal of Medicine. 2015 ; 373( 14): 1295-1306.Available from: http://dx.doi.org/10.1056/NEJMoa1507574
Artigo de periodico
Initiation of antiretroviral therapy in early asymptomatic HIV infection (2015)
; Casseb, Jorge Simão do Rosário
Source: The New England Journal of Medicine. Unidade: IMT
Subjects: INFECÇÕES POR HIV, TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
,; CASSEB, Jorge Simão do Rosário. Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine, London, v. 373, n. 9, p. 795-807, 2015. Disponível em: < http://dx.doi.org/10.1056/NEJMoa1506816 > DOI: 10.1056/NEJMoa1506816.
APA
,, & Casseb, J. S. do R. (2015). Initiation of antiretroviral therapy in early asymptomatic HIV infection. The New England Journal of Medicine, 373( 9), 795-807. doi:10.1056/NEJMoa1506816
NLM
, Casseb JS do R. Initiation of antiretroviral therapy in early asymptomatic HIV infection [Internet]. The New England Journal of Medicine. 2015 ; 373( 9): 795-807.Available from: http://dx.doi.org/10.1056/NEJMoa1506816
Vancouver
, Casseb JS do R. Initiation of antiretroviral therapy in early asymptomatic HIV infection [Internet]. The New England Journal of Medicine. 2015 ; 373( 9): 795-807.Available from: http://dx.doi.org/10.1056/NEJMoa1506816
Artigo de periodico
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma (2015)
Robak, Tadeusz; Huang, Huiqiang; Jun, Jie; Zhu, Jun; Liu, Ting; Samoilova, Olga; Pylpenko, Halyna; Verhoef, Gregor; Siritanaratkul, Noppadol; Osmanov, Evgenii; Alexeeva, Julia; Pereira, Juliana; Drach, Johannes; Mayer, Jiri; Hong, Xiaonan; Okamoto, Rumiko; Pei, Lixia; Rooney, Brendan; van de Velde, Helgi; Cavalli, Franco
Source: The New England Journal of Medicine. Unidade: FM
Subjects: LINFOMA (DIAGNÓSTICO;TRATAMENTO), FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, MORTALIDADE, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROBAK, Tadeusz; HUANG, Huiqiang; JUN, Jie; et al. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. The New England Journal of Medicine, Boston, v. 372, n. 8, p. 944-953, 2015. Disponível em: < http://www.nejm.org/doi/full/10.1056/NEJMoa1412096 > DOI: 10.1056/NEJMoa1412096.
APA
Robak, T., Huang, H., Jun, J., Zhu, J., Liu, T., Samoilova, O., et al. (2015). Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma. The New England Journal of Medicine, 372( 8), 944-953. doi:10.1056/NEJMoa1412096
NLM
Robak T, Huang H, Jun J, Zhu J, Liu T, Samoilova O, Pylpenko H, Verhoef G, Siritanaratkul N, Osmanov E, Alexeeva J, Pereira J, Drach J, Mayer J, Hong X, Okamoto R, Pei L, Rooney B, van de Velde H, Cavalli F. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma [Internet]. The New England Journal of Medicine. 2015 ; 372( 8): 944-953.Available from: http://www.nejm.org/doi/full/10.1056/NEJMoa1412096
Vancouver
Robak T, Huang H, Jun J, Zhu J, Liu T, Samoilova O, Pylpenko H, Verhoef G, Siritanaratkul N, Osmanov E, Alexeeva J, Pereira J, Drach J, Mayer J, Hong X, Okamoto R, Pei L, Rooney B, van de Velde H, Cavalli F. Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma [Internet]. The New England Journal of Medicine. 2015 ; 372( 8): 944-953.Available from: http://www.nejm.org/doi/full/10.1056/NEJMoa1412096
Artigo de periodico
Long-term use of ticagrelor in patients with prior myocardial infarction (2015)
Bonaca, Marc P.; Bhatt, Deepak L.; Cohen, Marc; Steg, Philippe Gabriel; Storey, Robert F.; Jensen, Eva C.; Magnani, Giulia; Bansilal, Sameer; Fish, M. Polly; Im, Kyungah; Bengtsson, Olof; Ophuis, Ton Oude; Budaj, Andrzej; Theroux, Pierre; Ruda, Mikhail; Hamm, Christian; Goto, Shinya; Spinar, Jindrich; Nicolau, José Carlos; Kiss, Robert G.; Murphy, Sabina A.; Wiviott, Stephen D.; Held, Peter; Braunwald, Eugene; Sabatine, Marc S.; Marin Neto, José Antonio
Source: The New England Journal of Medicine. Unidades: FM, FMRP
Subjects: FATORES DE RISCO, INFARTO DO MIOCÁRDIO, ADESÃO À MEDICAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONACA, Marc P.; BHATT, Deepak L.; COHEN, Marc; et al. Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine, Boston, v. 372, n. 19, 2015. Disponível em: < http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260 > DOI: 10.1056/NEJMoa1500857.
APA
Bonaca, M. P., Bhatt, D. L., Cohen, M., Steg, P. G., Storey, R. F., Jensen, E. C., et al. (2015). Long-term use of ticagrelor in patients with prior myocardial infarction. The New England Journal of Medicine, 372( 19). doi:10.1056/NEJMoa1500857
NLM
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, Marin Neto JA. Long-term use of ticagrelor in patients with prior myocardial infarction [Internet]. The New England Journal of Medicine. 2015 ; 372( 19):Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260
Vancouver
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS, Marin Neto JA. Long-term use of ticagrelor in patients with prior myocardial infarction [Internet]. The New England Journal of Medicine. 2015 ; 372( 19):Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260
Artigo de periodico
Driving Pressure and Survival in the Acute Respiratory Distress Syndrome (2015)
Amato, Marcelo B. P.; Meade, Maureen O.; Slutsky, Arthur S.; Brochard, Laurent; Costa, Eduardo L. V.; Schoenfeld, David A.; Stewart, Thomas E.; Briel, Matthias; Talmor, Daniel; Mercat, Alain; Richard, Jean-Christophe M.; Carvalho, Carlos R. R.; Brower, Roy G.
Source: The New England Journal of Medicine. Unidade: FM
Subjects: PULMÃO (LESÕES), SÍNDROME DO DESCONFORTO RESPIRATÓRIO EM ADULTOS, PRESSÃO SANGUÍNEA, RESPIRAÇÃO ARTIFICIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMATO, Marcelo B. P.; MEADE, Maureen O.; SLUTSKY, Arthur S.; et al. Driving Pressure and Survival in the Acute Respiratory Distress Syndrome. The New England Journal of Medicine, Boston, v. 372, n. 8, p. 747-755, 2015. Disponível em: < http://www.nejm.org/doi/pdf/10.1056/NEJMsa1410639 > DOI: 10.1056/NEJMsa1410639.
APA
Amato, M. B. P., Meade, M. O., Slutsky, A. S., Brochard, L., Costa, E. L. V., Schoenfeld, D. A., et al. (2015). Driving Pressure and Survival in the Acute Respiratory Distress Syndrome. The New England Journal of Medicine, 372( 8), 747-755. doi:10.1056/NEJMsa1410639
NLM
Amato MBP, Meade MO, Slutsky AS, Brochard L, Costa ELV, Schoenfeld DA, Stewart TE, Briel M, Talmor D, Mercat A, Richard J-CM, Carvalho CRR, Brower RG. Driving Pressure and Survival in the Acute Respiratory Distress Syndrome [Internet]. The New England Journal of Medicine. 2015 ; 372( 8): 747-755.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMsa1410639
Vancouver
Amato MBP, Meade MO, Slutsky AS, Brochard L, Costa ELV, Schoenfeld DA, Stewart TE, Briel M, Talmor D, Mercat A, Richard J-CM, Carvalho CRR, Brower RG. Driving Pressure and Survival in the Acute Respiratory Distress Syndrome [Internet]. The New England Journal of Medicine. 2015 ; 372( 8): 747-755.Available from: http://www.nejm.org/doi/pdf/10.1056/NEJMsa1410639
Artigo de periodico
Ezetimibe added to statin therapy after acute coronary syndromes (2015)
Cannon, Christopher P.; Blazing, Michael A.; Giugliano, Robert P.; McCagg, Amy; White, Jennifer A.; Theroux, Pierre; Darius, Harald; Lewis, Basil S.; Ophuis, Ton Oude; Jukema, J. Wouter; Ferrari, Gaetano M. De; Ruzyllo, Witold; De Lucca, Paul; Im, KyungAh; Bohula, Erin A.; Reist, Craig; Wiviott, Stephen D.; Tershakovec, Andrew M.; Musline, Thomas A.; Braunwald, Eugene; Califf, Robert M.; Marin Neto, José Antonio; Schmidt, André
Source: The New England Journal of Medicine. Unidade: FMRP
Subjects: DOENÇAS CARDIOVASCULARES, SÍNDROME CORONARIANA AGUDA, TERAPÊUTICA MÉDICA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANNON, Christopher P.; BLAZING, Michael A.; GIUGLIANO, Robert P.; et al. Ezetimibe added to statin therapy after acute coronary syndromes. The New England Journal of Medicine, Waltham, v. 372, n. 25, p. 2387-2397, 2015. Disponível em: < http://dx.doi.org/10.1056/NEJMoa1410489 > DOI: 10.1056/NEJMoa1410489.
APA
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., et al. (2015). Ezetimibe added to statin therapy after acute coronary syndromes. The New England Journal of Medicine, 372( 25), 2387-2397. doi:10.1056/NEJMoa1410489
NLM
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, Ferrari GMD, Ruzyllo W, De Lucca P, Im KA, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musline TA, Braunwald E, Califf RM, Marin Neto JA, Schmidt A. Ezetimibe added to statin therapy after acute coronary syndromes [Internet]. The New England Journal of Medicine. 2015 ; 372( 25): 2387-2397.Available from: http://dx.doi.org/10.1056/NEJMoa1410489
Vancouver
Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, Ferrari GMD, Ruzyllo W, De Lucca P, Im KA, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musline TA, Braunwald E, Califf RM, Marin Neto JA, Schmidt A. Ezetimibe added to statin therapy after acute coronary syndromes [Internet]. The New England Journal of Medicine. 2015 ; 372( 25): 2387-2397.Available from: http://dx.doi.org/10.1056/NEJMoa1410489
Artigo de periodico
Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease (2014)
White, Harvey D.; Held, Claes; Stewart, Ralph; Tarka, Elizabeth; Brown, Rebekkah; Davies, Richard Y.; Budaj, Andrzej; Harrington, Robert A.; Steg, P. Gabriel; Ardissino, Diego; Armstrong, Paul W.; Avezum, Alvaro; Aylward, Philip E.; Bryce, Alfonso; Chen, Hong; Chen, Ming-Fong; Corbalan, Ramon; Dalby, Anthony J.; Danchin, Nicolas; De Winter, Robbert J.; Denchev, Stefan; Diaz, Rafael; Elisaf, Moses; Flather, Marcus D.; Goudev, Assen R.; Granger, Christopher B.; Grinfeld, Liliana; Hochman, Judith S.; Husted, Steen; Kim, Hyo-Soo; Koenig, Wolfgang; Linhart, Ales; Lonn, Eva; López-Sendón, José; Manolis, Athanasios J.; Mohler III, Emile R.; Nicolau, José C.; Pais, Prem; Parkhomenko, Alexander; Pedersen, Terje R.; Pella, Daniel; Ramos-Corrales, Marco A.; Ruda, Mikhail; Sereg, Mátyás; Siddique, Saulat; Sinnaeve, Peter; Smith, Peter; Sritara, Piyamitr; Swart, Henk P.; Sy, Rody G.; Teramoto, Tamio; Tse, Hung-Fat; Watson, David; Weaver, W. Douglas; Weiss, Robert; Viigimaa, Margus; Vinereanu, Dragos; Zhu, Junren; Cannon, Christopher P.; Wallentin, Lars
Source: The New England Journal of Medicine. Unidade: FM
Subjects: DOENÇAS CARDIOVASCULARES (PREVENÇÃO E CONTROLE), ARTERIOSCLEROSE CORONÁRIA, FOSFOLIPASES A, REAÇÃO EM CADEIA POR POLIMERASE, BIOLOGIA MOLECULAR, ANÁLISE SEQUENCIAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WHITE, Harvey D.; HELD, Claes; STEWART, Ralph; et al. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease. The New England Journal of Medicine, Boston, v. 370, n. 18, p. 1702-1711, 2014. Disponível em: < http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260 > DOI: 10.1056/NEJMoa1315878.
APA
White, H. D., Held, C., Stewart, R., Tarka, E., Brown, R., Davies, R. Y., et al. (2014). Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease. The New England Journal of Medicine, 370( 18), 1702-1711. doi:10.1056/NEJMoa1315878
NLM
White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler III ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease [Internet]. The New England Journal of Medicine. 2014 ; 370( 18): 1702-1711.Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260
Vancouver
White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen M-F, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim H-S, Koenig W, Linhart A, Lonn E, López-Sendón J, Manolis AJ, Mohler III ER, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse H-F, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L. Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease [Internet]. The New England Journal of Medicine. 2014 ; 370( 18): 1702-1711.Available from: http://link.periodicos.capes.gov.br/sfxlcl41?url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&ctx_enc=info:ofi/enc:UTF-8&ctx_ver=Z39.88-2004&rfr_id=info:sid/sfxit.com:azlist&sfx.ignore_date_threshold=1&rft.object_id=954925428260

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration